Update on the Diagnosis and Anticoagulant Treatment of the Antiphospholipid Syndrome
Antiphospholipid syndrome (APS) is an acquired form of thrombophilia characterised by the presence of antiphospholipid antibodies and arterial/venous thrombosis or obstetric complications. Although antiphospholipid antibodies are reported in 1–5% of the general population, only a minority of these i...
Main Authors: | Nicoletta Riva, Alex Gatt |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2019-07-01
|
Series: | European Medical Journal Rheumatology |
Subjects: | |
Online Access: | https://www.emjreviews.com/rheumatology/article/update-on-the-diagnosis-and-anticoagulant-treatment-of-the-antiphospholipid-syndrome/ |
Similar Items
-
Direct-acting oral anticoagulants in antiphospholipid syndrome
by: T. M. Reshetnyak, et al.
Published: (2021-01-01) -
Update on laboratory practice for the diagnosis of lupus anticoagulant and the antiphospholipid syndrome
by: Osamu Kumano, et al.
Published: (2023-10-01) -
Strategies of anticoagulant therapy in various clinical variants of antiphospholipid syndrome
by: A. A. Klimenko, et al.
Published: (2024-06-01) -
Clinical case of rheumatoid arthritis with antiphospholipid antibody syndrome
by: G. G Arabidze, et al.
Published: (2015-09-01) -
Right Atrial Thrombosis in Antiphospholipid Syndrome with Secondary Immune Thrombocytopenia
by: Minna Voigtlaender, et al.
Published: (2015-04-01)